Meeting
2021 ASCO Annual Meeting
Improving patient and caregiver understanding of risks and benefits of immunotherapy for melanoma or lung cancer.
Presenter
Laura A Petrillo, MD
Massachusetts General Hospital and Harvard Medical School
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Quality Improvement
Clinical Trial Registration Number
04670445
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr TPS6596)
DOI
10.1200/JCO.2021.39.15_suppl.TPS6596
Abstract #
TPS6596
Poster Bd #
Online Only
Abstract Disclosures
Funded by Conquer Cancer
Similar Videos & Slides
Videos & Slides
2023 ASCO Annual Meeting
A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non–small-cell lung cancer and melanoma.
Speaker: Yuval Shaked, PhD, BSc
Videos & Slides
2021 ASCO Annual Meeting
Knowledge about risks, benefits, and curative potential of immunotherapy among patients with advanced lung cancer or melanoma.
Speaker: Laura A Petrillo, MD
Videos & Slides
2024 ASCO Annual Meeting
Patient and caregiver experience with the hope and prognostic uncertainty of immunotherapy: A qualitative study.
Speaker: Mary Catherine Boulanger
Videos & Slides
2024 ASCO Annual Meeting
Development of a novel granulocyte scoring system for use as a predictive/prognostic biomarker in patients with advanced melanoma undergoing treatment with combination immunotherapy.
Speaker: Max Julve, MBBS